Xiaohan_Hu

Xiaohan Hu PhD, MPH

Merck & Co Inc

Appearances

Biomarker Testing, Surgical Outcomes, and Adjuvant Therapy Rates Among Patients with Resected Non-Small Cell Lung Cancer (NSCLC) in the Community Setting in the United States (US), 2019–2023
Date
April 6, 2024
Abstract: JNCCN23-0676 https://jnccn.org/view/journal... [https://jnccn.org/view/journals/jnccn/22/2.5/article-pHSR24-161…
Speaker
Xiaohan Hu, PhD, MPH
Merck & Co Inc
Updates in Oncology: Oral Presentations from the NCCN Poster Sessions
Date
April 6, 2024
Not a CE-certified activity…
Moderator
Wallace Akerley, MD
Huntsman Cancer Institute
Speakers
Alexandrina Balanean, MPH
Lead Publication Scientist, Strategic Research, Cardinal Health Inc
Danielle Brabender, MD
University of Southern California Keck School of Medicine
Xiaohan Hu, PhD, MPH
Merck & Co Inc
Yazan Madanat, MD
UT Southwestern Simmons Comprehensive Cancer Center
Adrianna Oraiqat, BS
Pancreas Cancer Care Coordinator, Moffitt Cancer Center